THC vs UHS
THC: Tenet Healthcare is a leading diversified healthcare services provider focused on high-quality inpatient hospital care and a rapidly expanding network of ambulatory surgery centers. UHS: A diversified operator of a massive network of inpatient behavioral health centers and acute care hospitals across the US and UK.
Side-by-side fundamentals
| Metric | THC | UHS | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $260.57 | $175.72 | |
| Market cap | $21.0B | $10.4B | |
| P/E as of 2026-10-08 | 10.05 | 7.16 | UHS lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2025 | 0.17 | 0.20 | THC lower |
| Net margin FY2025, SEC XBRL | +11.1% | +8.6% | THC higher |
| Operating margin FY2025, SEC XBRL | +16.5% | +11.5% | THC higher |
| ROE FY2025, SEC XBRL | +39.3% | +20.3% | THC higher |
| ROA FY2025, SEC XBRL | +8.0% | +9.6% | UHS higher |
| Debt / equity as of 2026-09-02 | 2.84 | 0.65 | UHS lower |
| Revenue growth (YoY) as of 2026-09-02 | +7.4% | +10.1% | UHS higher |
| Revenue CAGR (3y) SEC XBRL | +3.6% | +9.0% | UHS higher |
| Dividend yield as of 2026-09-02 | n/a | +0.5% | |
| Dividend streak (yrs) SEC XBRL | 0 | 5 | UHS higher |
| Beta as of 2026-09-02 | 0.80 | 0.49 | |
| 1-year return as of 2026-10-08 close | +30.0% | -14.4% | THC higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.